Student Information Training Programs Research Centers

Pharmacology & Toxicology

Research and Graduate Training Faculty

Photo

Wilcox, Richard E., Ph.D.
Assistant Dean for Admissions/Advising
James T. Doluisio Centennial
Fellowship in Pharmacy
Professor of Pharm./Tox.
PHR 5.112B
512-471-1737
wilcoxrich@austin.utexas.edu


Recent Publications
  • Brusniak, M. Y., R. S. Pearlman, et al. (1996). "Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors." Journal of Medicinal Chemistry 39(4): 850-9.

  • Mak, C. K., M. Avalos, et al. (1996). "Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines." Neuropharmacology 35(5): 549-70.

  • Erickson, C. K., R. E. Wilcox, et al. (1998). "Education of nonscientists about new alcohol research: results of two types of presentations plus 6-month follow-up." Alcoholism: Clinical & Experimental Research 22(9): 1890-7.

  • Wilcox, R. and B. McMillen (1998). "The rational use of drugs as therapeutic agents for the treatment of the alcoholisms." Alcohol. 15(2): 161-77.

  • Wilcox, R., T. Tseng, et al. (1998). "CoMFA-based prediction of agonist affinities at recombinant D1 vs. D2 dopamine receptors." J. Med. Chem. 41: 4385-4399.

  • Wilcox, R. E., R. A. Gonzales, et al. (1998). Introduction to neurotransmitters, receptors, signal transduction and second messengers. Textbook of Psychopharmacology. C. B. Nemeroff and A. F. Schatzberg, American Psychiatric Press: 3-36.

  • Avalos, M. A., C. Mak, et al. (2000). "Non-linear analysis of partial dopamine agonist effects on camp in c6 glioma cells." J. Pharm. Tox. Meth. 45: 17-37.

  • Edwards, S., S. L. Hoyler, et al. (2000). "Beta2-adrenoreceptor inverse agonists enhance cAMP accumulation via up-regulation of functional receptor density at the cell surface." Soc. Neuroscience Abstr 26: 116 (45.14).

  • Galindo, D., S. Edwards, et al. (2000). "Comparative effects of a full D1 agonist, a D2 receptor agonist, and ethanol on the phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor." Society for Neuroscience Abstracts 30: 786 (#290.6).

  • Raofi, S., P. K. Wong, et al. (2000). "Modulation of G-protein linked cAMP accumulation in immortalized murine cortical astrocytes by retroviral infection." Brain Research 862(1-2): 230-3.

  • Wilcox, R. E. (2000). Dopamine. Encyclopedia of Psychology and Neuroscience, 3rd edition. W. E. Craighead and C. B. Nemeroff. New York, John Wiley. 1: 454-457.

  • Wilcox, R. E. and C. K. Erickson (2000). "Commentary - Neurobiological aspects of the addictions." J. Addictions Nursing, 12(3/4), 117-133 12(3/4): 117-133.

  • Wilcox, R. E., W.-H. Huang, et al. (2000). "CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors." Journal of Medicinal Chemistry 43(16): 3005-3019.

  • Wilcox, R. E., J. E. Ragan, et al. (2000). "High-affinity agonist interactions at recombinant 5HT7 receptors - estimates using CoMFA (comparative molecular field analysis)." Soc. Neuroscience Abstr. 26: 2157 (810.9).

  • Chu, J., W. Wilczynski, et al. (2001). " Pharmacological Characterization of the D1 and D2-like Dopamine Receptors from the Brain of the Leopard Frog, Rana pipiens." Brain Behavior and Evolution 57: 328-342.

  • Doherty, J. M. and R. E. Wilcox (2001). "Acute in vivo dopaminergic drug effects on striatal versus nucleus accumbens protein phosphorylation." Bain Research: in progress.

  • Erickson, C. K. and R. E. Wilcox (2001). "Pharmacology of addiction." Tex. Pharm. Assoc. J. winter: 8-13.

  • Erickson, C. K. and R. E. Wilcox (2001). "Neurobiological causes of addictions." J. Social Work Practice in the Addictions 1(3): 7-22.

  • Wilcox, R. E. and C. K. Erickson (2001). Brain biology of drug abuse and addiction. Neurobiology of Addictions - Implications for Clinical Practice. R. T. Spence, D. M. DiNitto and S. L. A. Straussner. Binghamton, NY, Haworth Press, Inc.: 7-23.

  • Wilcox, R. E., J. E. Ragan, et al. (2001). "High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors." J. Computer-Aided Molecular Design 15: 883-909.

  • Edwards, S., S. L. Hoyler, et al. (2002). "Sensitization of beta2-adrenoreceptor-mediated cAMP generation after chronic exposure to inverse agonists." British J. Pharmacology: in preparation.

  • Edwards, S., D. Simmons, et al. (2002). "Antagonistic Effects of Dopaminergic Signaling and Ethanol on PKA-Mediated Phosphorylation of DARPP-32 and the NR1 Subunit of the NMDA Receptor." Alcoholism: Clinical and Experimental Research 26(2): 173-180.

  • Huang, W.-H., R. E. Wilcox, et al. (2002). "Comparative Molecular Field Analysis (CoMFA) for sulfoxidation reactions in Mortierella isabellina ATCC 42613 and Helminthosporim sp. NRRL 4671." J. Molecular Modeling 8: 8-23.

  • Scott, A., J. Doherty, et al. (2002). "Oxotremorine-M, oxotremorine-S, and eticlopride/naltrexone, but not fluoxetine, enhance striatal phosphorylation of the NMDA-R1 receptor subunit in mice following acute in vivo challenge." Brain Research: in preparation.

  • Trzeciakowskii, J. P. and R. E. Wilcox (2002). "Estimating the relative efficacy of partial dopamine receptor agonists in recombinant receptor expression systems: Comparison of functional interaction and combined effects models." J. Thoretical Biol.: submitted.

  • Doddakashi, V., L. Hauser, et al. (2003). "Female suicide in Texas 1994 -1998." Texas Medicine: in press.

  • Erickson, C. K., R. E. Wilcox, et al. (2003). "Effectiveness of Addiction Science Presentations to Treatment Professionals, Using a Modified Solomon Study Design." Journal of Drug Education in press.

  • Lawson, K. A., R. E. Wilcox, et al. (2003). "Educating Professionals to Promote Addiction Science Research: Demographics of Knowledge and Belief Changes." Substance Abuse and Misuse 2003.

  • Li, S., D. Simmons, et al. (2003). "Acute in vivo challenge with the antidepressant fluoxetine enhances expression of striatal pDARPP-32, an effect that is reversed by ethanol." J. Neural Trans.: in preparation.

  • Wilcox, R. E. and C. K. Erickson (2003). "Prevention of relapse to addiction - information for the practitioner." Texas Medicine submitted.
More information about Dr. Wilcox
> Return to Wilcox's Home Page


(Download PDF Reader.)

Last Reviewed: June 15, 2009

Division Information

Mailing Address:
Pharmacology & Toxicology
College of Pharmacy
The University of Texas
at Austin
107 W. Dean Keeton
Stop C0875
Austin, TX, USA
78712

Email Address: pharmtox
@austin.utexas.edu

Phone: 512-471-5158


Parkinson Gene Link May Aid Battle Against Disease

Dr. Som Mukhopad-
hyay led the research team that focused on the gene SLC30A10 and its role as a "door opener" in helping to remove elevated levels of manganese from cells. The study was published in the Oct. 15, 2014 issue of The Journal of Neuroscience.

> Read more about Dr. Mukhopadhyay's research.


Erickson Authors New Book

"Drugs, the Brain and Behavior" is co-authored by Dr. Carlton Erickson, the college's associate dean for research and graduate studies, and Dr. John Brick, executive director of Intoxikon International.

> Read more about Dr. Erickson's new book.


Gore receives SEBM award

Andrea Gore is named to the SEBM Distinguished Scientist Award.

> Read more about Dr. Gore's new award.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z